文献速递主动脉疾病

GREAT注册研究中开放与经皮入路结局对比

Outcomes of Open Versus Percutaneous Access for Patients Enrolled in the GREAT Registry.
PubMed 文献 · Ann Vasc Surg · 2020-06-27

基于GREAT注册研究4781例患者回顾性分析,其中EVAR 3837例(80.3%)、TEVAR 944例(19.7%),比较经皮、切开及联合入路的结局。六组间入路部位并发症无显著差异,但纯经皮入路并发症显著低于纯切开和联合入路(P=0.03),且住院时间更长与并发症显著相关(P<0.01)。

要点

  • 纯经皮入路并发症率显著低于切开或联合入路(P=0.03)。
  • 入路部位并发症与更长住院时间显著相关(P<0.01)。
  • 增大鞘管尺寸未见增加入路并发症风险。

核心结论

  • 经皮与切开入路的并发症率无显著差异。
  • 纯经皮入路安全、并发症率低,且住院时间低于开放或联合入路。

研究设计与样本

  • 回顾性分析GREAT注册研究(NCT01658787)4781例患者。
  • 按EVAR与TEVAR及纯经皮、纯切开、联合入路分为6组。

主要发现

  • EVAR 3837例(80.3%),TEVAR 944例(19.7%)。
  • 纯经皮入路2017例(42.2%),纯切开入路2446例(51.2%)。
  • 六组间入路部位并发症率无显著差异。
  • 纯经皮入路并发症率显著低于纯切开和联合入路(P=0.03)。
  • 住院时间更长与入路部位并发症显著相关(P<0.01)。

关键数值与推荐

  • 平均住院时间5.2天,TEVAR组10.1天高于EVAR组4.0天(P<0.05)。
  • 经皮入路使用率存在地区差异,澳大利亚和新西兰最高,巴西最低。

临床怎么用

  • EVAR和TEVAR可优先考虑纯经皮入路以降低并发症和住院时间。
  • 需关注住院时间延长患者的入路部位并发症风险。

局限性

  • 回顾性研究设计。
  • 地区入路选择差异可能影响结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arterial access and device delivery in endovascular aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR) have evolved from open femoral or iliac artery exposure to selective percutaneous arterial access. Although regional application of percutaneous access for these 2 procedures varies widely, the use of this technique continues to increase. Currently, differences in the use of percutaneous access between EVAR and TEVAR have not been well explored. The Gore Global Registry for Endovascular Aortic Treatment (GREAT) registry collected relevant data for evaluation of these issues and the comparative results between open and percutaneous approaches in regard to complication rates and length of stay (LOS). METHODS: This study was performed via a retrospective review of patients from the GREAT registry (Clinicaltrials.gov no. NCT01658787). The primary variable of this study was access site complications including postoperative hematoma, vessel dissection, and pseudoaneurysm. Patients were categorized by abdominal (EVAR) and thoracic (TEVAR) aortic procedures using percutaneous-only, cutdown-only, and combined vascular access techniques for a total of 6 groups. Standard statistical methodology was used to perform single-variable and multivariable analysis of a variety of covariates including LOS, geographical location of procedure, procedural success rate, and access sheath size. RESULTS: Of 4,781 patients from the GREAT registry, 3,837 (80.3%) underwent EVAR and 944 (19.7%) underwent TEVAR with percutaneous-only access techniques being used in 2,017 (42.2%) and cutdown-only in 2,446 (51.2%). There was variable application of percutaneous access by geographic region with Australia and New Zealand using this technique more frequently and Brazil using percutaneous access the least. No significant difference in the rate of access site complications was detected between the 6 groups of patients in the study; however, significantly lower rates of access site complications were associated with percutaneous-only compared with both cutdown-only and combined techniques (P = 0.03). In addition, associated with significantly higher rates of access site complications was longer LOS (P < 0.01). Average LOS was 5.2 days and was higher in the TEVAR group (10.1 days) than that in EVAR (4.0 days, P < 0.05). Increased sheath size does not appear to increase the risk of access site complication. CONCLUSIONS: There was no significant difference found in the complication rate between percutaneous and cutdown access techniques. This analysis demonstrates that percutaneous-only access is safe, has low complication rates, and has lower LOS compared with open access or combined access techniques.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Baxter RD, Hansen SK, Gable CE, et al. Outcomes of Open Versus Percutaneous Access for Patients Enrolled in the GREAT Registry. Ann Vasc Surg. 2020. PMID: 32603847. doi:10.1016/j.avsg.2020.06.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。